Overview

Effect of DPP-IV Inhibitor on Glycemic Control and Autonomic Neuropathy in Adult Patients With Diabetes Mellitus

Status:
Unknown status
Trial end date:
2013-01-01
Target enrollment:
0
Participant gender:
All
Summary
Rocca et al. reported first that the secretion of incretins, particular GLP-1 in rat is regulated by the enteric nervous system, the afferent and efferent vagus nerves [1]. Further, Kazakos et al. [2] reported that autonomic nerve disturbance (AND) in patients with T2DM impaired the incretin effect owing to decreased GLP-1 secretion. However, Toft-Nielsen et al. [3] reported that the decreased GLP-1 responses in the patients with type 2 diabetes mellitus (T2DM) are unlikely to be related to the AND and, thus, did not support the results of Rocca et al. and Kazakos et al. Recently, Yabe at al. [4] also observed the same observations in Japanese patients with T2DM. Meanwhile, Jin et al. reported that administration of DPP-IV inhibitor recovered the disturbance of diabetic nerve dysfunction in rat [5]. However, it is unknown whether the administration of DPP-IV inhibitor effects on the AND in human, although many studies are performed to investigate the effect of the DPP-IV inhibitors on glycemic control. Accordingly, it is significant to reinvestigate an effect of DPP-IV inhibitor on glycemic control and autonomic neuropathy in diabetic patients.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Nagaoka Red Cross Hospital
Treatments:
Sitagliptin Phosphate
Criteria
Inclusion Criteria:

type 1 and 2 diabetes mellitus patients

- Patients who have AND determined by C.V. R-R.

- Outpatients regularly visiting hospital

- Patients 20 years old (gender is disregarded)

Exclusion Criteria:

Patients with a serious complication in the heart, liver or kidney

- Pregnant or possibly pregnant patients, or lactating patients

- Patients complicated with a malignant tumor at present.

- Patients participating in other clinical study.

- Other than the above, patients judged inappropriate as the subjects of this study by
the investigator